Poster sale · Free shipping over $80 · Red tag edit
Login Reg

CRA HINDS LIQ RSA RCA 90ML LE ROY Cáncer de mama HER2 positivo

SKU 5044512905
4.1
USD20.41 USD56.41

Pay in 4 interest-free payments of $5.10 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 8 - Aug 13

CRA HINDS LIQ RSA RCA 90ML LE ROY Cáncer de mama HER2 positivo
CRA HINDS LIQ RSA RCA 90ML LE ROY Cáncer de mama HER2 positivo
CRA HINDS LIQ RSA RCA 90ML LE ROY Cáncer de mama HER2 positivo
CRA HINDS LIQ RSA RCA 90ML LE ROY Cáncer de mama HER2 positivo
Description

Cáncer de mama HER2 positivo residual tras terapia neoadyuvante

Administrar por vía subcutánea o intravenosa según prescripción médica

Vía de aplicación: Corporal

CYRAMZA® es un medicamento de uso intravenoso que contiene Ramucirumab

CRA HINDS LIQ RSA RCA 90ML LE ROY Cáncer de mama HER2 positivo

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products